INSMED Inc financial data

Symbol
INSM on Nasdaq
Industry
Pharmaceutical Preparations
Location
700 Us Highway 202/206, Bridgewater, NJ
State of incorporation
VA
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 20, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 363 % -26.8%
Quick Ratio 24.6 % -35.2%
Debt-to-equity 1.96K %
Return On Equity -1.07K % -392%
Return On Assets -51.9 % +2.94%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 181M shares
Common Stock, Shares, Outstanding 179M shares +21.2%
Entity Public Float 11B USD +267%
Common Stock, Value, Issued 1.79M USD +21.2%
Weighted Average Number of Shares Outstanding, Basic 164M shares +16.8%
Weighted Average Number of Shares Outstanding, Diluted 164M shares +16.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 364M USD +19.2%
Research and Development Expense 598M USD +4.79%
General and Administrative Expense 408M USD +24.3%
Costs and Expenses 1.24B USD +22.4%
Operating Income (Loss) -878M USD -23.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -910M USD -21.8%
Income Tax Expense (Benefit) 3.71M USD +45.1%
Net Income (Loss) Attributable to Parent -914M USD -21.9%
Earnings Per Share, Basic -5.57 USD/shares -4.31%
Earnings Per Share, Diluted -5.57 USD/shares -4.31%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 555M USD +15.1%
Marketable Securities, Current 879M USD +195%
Accounts Receivable, after Allowance for Credit Loss, Current 52M USD +26.3%
Inventory, Net 98.6M USD +18.4%
Assets, Current 1.62B USD +74.5%
Property, Plant and Equipment, Net 80.1M USD +22.4%
Operating Lease, Right-of-Use Asset 17.3M USD -4.22%
Goodwill 136M USD 0%
Assets 2.03B USD +52.3%
Accounts Payable, Current 73M USD +11.7%
Employee-related Liabilities, Current 80.3M USD +64.1%
Liabilities, Current 298M USD +31.9%
Operating Lease, Liability, Noncurrent 9.11M USD -17.3%
Other Liabilities, Noncurrent 499K USD -84.1%
Liabilities 1.74B USD +4.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.29M USD -207%
Retained Earnings (Accumulated Deficit) -4.36B USD -26.5%
Stockholders' Equity Attributable to Parent 285M USD
Liabilities and Equity 2.03B USD +52.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -184M USD -25.8%
Net Cash Provided by (Used in) Financing Activities 3.02M USD
Net Cash Provided by (Used in) Investing Activities 295M USD +610%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 179M shares +21.2%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 113M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 555M USD +15.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8.21M USD -29.2%
Deferred Tax Assets, Valuation Allowance 1.13B USD +24.5%
Deferred Tax Assets, Gross 1.14B USD +23.3%
Operating Lease, Liability 18.5M USD -3.02%
Depreciation 1.59M USD +27.2%
Payments to Acquire Property, Plant, and Equipment 4.68M USD +37.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -915M USD -21.9%
Lessee, Operating Lease, Liability, to be Paid 21M USD +4.06%
Property, Plant and Equipment, Gross 130M USD +18.5%
Operating Lease, Liability, Current 9.36M USD +16.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.24M USD -48.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 10.6M USD +22.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +13.2%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.51M USD +125%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.7M USD +28.3%
Deferred Tax Assets, Operating Loss Carryforwards 673M USD +19.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Unrecognized Tax Benefits 19M USD +28.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.46M USD +276%
Additional Paid in Capital 4.65B USD +49.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 5.05M USD 0%
Deferred Tax Assets, Net of Valuation Allowance 12.5M USD -33%
Interest Expense 84.9M USD +3.94%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%